These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19334766)

  • 1. Polymer-induced heteronucleation of tolfenamic acid: structural investigation of a pentamorph.
    López-Mejías V; Kampf JW; Matzger AJ
    J Am Chem Soc; 2009 Apr; 131(13):4554-5. PubMed ID: 19334766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pH, polymer concentration and molecular weight on the physical state properties of tolfenamic acid.
    Sheraz MA; Ahmed S; Ur Rehman I
    Pharm Dev Technol; 2015 May; 20(3):352-60. PubMed ID: 24417663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.
    López-Mejías V; Kampf JW; Matzger AJ
    J Am Chem Soc; 2012 Jun; 134(24):9872-5. PubMed ID: 22690822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards exhaustive and automated high-throughput screening for crystalline polymorphs.
    Pfund LY; Matzger AJ
    ACS Comb Sci; 2014 Jul; 16(7):309-13. PubMed ID: 24933573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolfenamic Acid.
    Ahmed S; Sheraz MA; Ahmad I
    Profiles Drug Subst Excip Relat Methodol; 2018; 43():255-319. PubMed ID: 29678262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorph formation and nucleation mechanism of tolfenamic acid in solution: an investigation of pre-nucleation solute association.
    Mattei A; Li T
    Pharm Res; 2012 Feb; 29(2):460-70. PubMed ID: 21879384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology study of progesterone polymorphs prepared by polymer-induced heteronucleation (PIHn).
    Araya-Sibaja AM; Fandaruff C; Campos CE; Soldi V; Cardoso SG; Cuffini SL
    Scanning; 2013; 35(4):213-21. PubMed ID: 23034679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.
    Frank DS; Matzger AJ
    Mol Pharm; 2018 Jul; 15(7):2714-2720. PubMed ID: 29924614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.
    Ahmed S; Sheraz MA; Rehman IU
    AAPS PharmSciTech; 2013 Jun; 14(2):870-9. PubMed ID: 23620261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
    Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
    J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and physical stability of tolfenamic acid-PVP K30 solid dispersions.
    Thybo P; Kristensen J; Hovgaard L
    Pharm Dev Technol; 2007; 12(1):43-53. PubMed ID: 17484143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationally Developed Organic Salts of Tolfenamic Acid and Its β-Alanine Derivatives for Dual Purposes as an Anti-Inflammatory Topical Gel and Anticancer Agent.
    Parveen R; Sravanthi B; Dastidar P
    Chem Asian J; 2017 Apr; 12(7):792-803. PubMed ID: 28150904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer-induced heteronucleation.
    Grzesiak AL; Matzger AJ
    J Pharm Sci; 2007 Nov; 96(11):2978-86. PubMed ID: 17567888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: structure and biological perspectives.
    Zampakou M; Rizeq N; Tangoulis V; Papadopoulos AN; Perdih F; Turel I; Psomas G
    Inorg Chem; 2014 Feb; 53(4):2040-52. PubMed ID: 24467343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of polymorphism and solvation in tranilast.
    Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
    J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
    Araya-Sibaja AM; Soldi V; Campos CE; Cardoso SG; Cuffini SL
    Drug Dev Ind Pharm; 2015 May; 41(5):851-8. PubMed ID: 24758712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
    Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
    J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphs, hydrates and solvates of a co-crystal of caffeine with anthranilic acid.
    Madusanka N; Eddleston MD; Arhangelskis M; Jones W
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):72-80. PubMed ID: 24441130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.
    Hurtado M; Sankpal UT; Chhabra J; Brown DT; Maram R; Patel R; Gurung RK; Simecka J; Holder AA; Basha R
    Invest New Drugs; 2019 Feb; 37(1):27-34. PubMed ID: 29761244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.